Media Releases

The Royal College of Pathologists of Australasia (RCPA) has expressed concern that a new cancer initiative announced by the New Zealand government fails to encompass pathology/laboratory testing services which are essential for the diagnosis of all cancers. The College strongly recommends that the Government address the funding and workforce requirements for these services as part of the New Zealand Cancer Action Plan.

The Royal College of Pathologists of Australasia (RCPA) has called on the Government to end the freeze on Medicare rebates for pathology testing which has been in place for over 20 years.  This follows the announcement from the Government that the current indexation freeze on all GP services on the MBS will be lifted from 1 July 2019, along with various diagnostic testing rebates from 1 July 2020.

Charles Sturt University (CSU) Associate Professor Shokoofeh Shamsi, a speaker at the Royal College of Pathologists of Australasia’s (RCPA) annual conference, ‘Pathology Update 2019 – The Power of Personalised Pathology’, which will take place at the Melbourne Convention and Exhibition Centre (MCEC) this weekend, will discuss her new research¹, published this month, on seafood-borne parasitic diseases.